Search Results

Active, currently enrolling    Who can join   

Case-Control Study II of Genomic Markers in Menstrual Blood for Diagnosis of Uterine Disorders

Keywords: Obstetrics and Gynecology;Endometriosis; Uterine Disorders
Study Type: OBSERVATIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES)

Keywords: Oncology (Adult); Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

(E5103) A DOUBLE-BLIND PHASE III TRIAL OF DOXORUBICIN AND CYCLOPHOSPHAMIDE FOLLOWED BY PACLITAXEL WITH BEVACIZUMAB OR PLACEBO IN PATIENTS WITH LYMPH NODE POSITIVE AND HIGH RISK LYMPH NODE NEGATIVE BREAST CANCER

Keywords: Oncology (Adult);Allergy and Immunology;Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

(NSABP B-42) A CLINICAL TRIAL TO DETERMINE THE EFFICACY OF FIVE YEARS OF LETROZOLE COMPARED TO PLACEBO IN PATIENTS COMPLETING FIVE YEARS OF HORMONAL THERAPY CONSISTING OF AN AROMATASE INHIBITOR (AI) OR TAMOXIFEN FOLLOWED BY AN AI IN PROLONGING DISEASE-FREE SURVIVAL IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE BREAST CANCER

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors

Keywords: Carcinoma; Neoplasms; Neoplasms; Germ Cell and Embryonal; Teratoma; Endodermal…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: OBSERVATIONAL   |  Region: California - Northern

---

Study completed    Who can join   

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---